Latest news with #KyleArmbrester
Business Wire
2 days ago
- Business
- Business Wire
Datavant to Acquire Ontellus to Transform Medical Record Retrieval with Tech-Enabled Health Records Retrieval and Claims Intelligence Solutions
NEW YORK--(BUSINESS WIRE)-- Datavant, a leading health data platform company, today announced that it has signed an agreement to acquire Ontellus, a leading provider of health records retrieval and claims intelligence from Aquiline, a private investment firm specializing in financial services and technology and Capstreet, a Houston-based lower middle market private equity firm. With this acquisition, Ontellus will join Datavant to deliver an integrated, digital-first platform that connects those with health records to those who need them easily, quickly and securely. In addition to driving value to providers, freeing up more of their time to focus on patient care, this acquisition will transform the experience for requesters from a largely manual and time consuming process to a more efficient, digital process. The combined organization will reduce administrative burden for Datavant's network of over 80,000 health care providers, clinics, hospitals and health system partners, who routinely manage requests for health records—vital for life insurance underwriting, injury claims, and legal case work. Today, the record retrieval process remains highly fragmented, with inconsistent workflows, procedures, and data formats across thousands of organizations. By joining forces, Datavant and Ontellus reaffirm their shared commitment to simplify this complexity and improve access to records to ensure that confidential health records are digitized in a secure and timely manner to authorized parties. 'Moving health data securely and compliantly from where it sits to where it needs to be in the right format to authorized users is one of the industry's biggest challenges,' said Datavant CEO Kyle Armbrester. 'In addition to driving value to our health care providers, freeing up more of their time to focus on patient care, this acquisition will transform the experience for requesters from a largely manual and time consuming process to a more efficient, digital process that leverages Datavant's deep expertise in privacy preservation and compliance. We are delighted to welcome Ontellus' world-class team and work with them to further transform the health data request process for all of our customers.' Ontellus has digitized its records retrieval business into a nationwide platform through which record requestors have direct access to providers. Additionally, through its canvassing services, Ontellus delivers detailed claimant treatment timelines to validate claims or uncover preexisting conditions, helping customers reduce unnecessary and costly claims exposure. Datavant will join Ontellus' capabilities with its own digital connectivity capabilities to create a highly tech-enabled integrated platform offering to better serve all customers. Ontellus CEO, Vince Cole, will join Datavant's Executive Leadership Team, reporting directly to Kyle Armbrester, Datavant CEO. 'By combining Ontellus' industry-leading request fulfillment infrastructure with Datavant's advanced connectivity and data exchange capabilities, we're enabling faster, more precise access to critical health information—not only for healthcare providers, but also for legal and insurance professionals who rely on timely, accurate data to support claims and compliance. We are deeply grateful to our investor partners, Aquiline Capital Partners and The Capstreet Group, whose strategic guidance and resources have powered our growth and product innovation,' said Vince Cole, CEO of Ontellus. Houlihan Lokey served as buyside financial advisor to Datavant, assisting in evaluating and negotiating the acquisition. Harris Williams is the sell-side advisor to Ontellus, representing the company in its pending sale to Datavant. About Datavant Datavant is a health data platform company. We make the world's health data secure, accessible, and actionable. Datavant drives data connectivity into action by offering a proprietary platform and network that deliver critical solutions across the healthcare ecosystem. Datavant enables more than 60 million healthcare records to move between thousands of organizations, more than 80,000 hospitals and clinics, 75% of the 100 largest health systems, and an ecosystem of 300+ real-world data partners. To learn more about Datavant, visit and follow us on LinkedIn. About Ontellus Ontellus empowers insurance carriers, self-insured corporations and law firms to reduce costs, make informed decisions and accelerate claims resolution. As one of the nation's largest, privately held data retrieval and claims intelligence providers, Ontellus leverages decades of experience and cutting-edge technology to deliver impactful products and client-centric services with industry-leading turnaround times. For more information, visit
Business Wire
15-05-2025
- Business
- Business Wire
Datavant to Acquire Aetion, Empowering Healthcare and Life Sciences Organizations to Generate High-Quality, Scalable Real-World Evidence from Connected, Privacy-Protected Data
NEW YORK--(BUSINESS WIRE)--Datavant, a leading health data platform company, today announced that it has signed an agreement to acquire Aetion, a leading real-world evidence (RWE) platform that powers critical decision-making in healthcare. With this acquisition, Aetion will join Datavant to deliver an end-to-end RWE platform, enabling healthcare and life sciences companies to more efficiently answer research questions about the clinical impact of therapies in development and in market. The companies will focus on leveraging their complementary capabilities to create an end-to-end offering on data discovery, linkage, privacy, curation and advanced analysis to enable their life sciences customers to create analytics-ready insights. Share This complementary combination unites two leaders to make RWE truly actionable, covering the full spectrum of services needed to deliver scientifically validated, transparent and reproducible RWE accepted by global regulators, including the FDA and EMA. Aetion brings industry-leading technology, services and data partners to help life science and medical device customers develop decision-grade evidence plans and analyses. Stakeholders across the healthcare value chain use Datavant's industry-standard platform for secure, compliant health data exchange to fuel connected, comprehensive insights that empower smarter decisions and advance patient outcomes. 'As Datavant has grown and scaled, our life sciences and ecosystem partners have been asking us for a deeper capability set to bring together disparate data sources so they can tap into a more comprehensive and longitudinal view of patient health across the product lifecycle," said Kyle Armbrester, Chief Executive Officer, Datavant. 'The addition of Aetion's team of scientists and technologists further bolsters our complementary capabilities and expertise so we can better leverage data from our ecosystem of partners to support efforts before, during, and after commercialization - generating evidence from trial to treatment and beyond to deliver life-improving therapies.' The companies will focus on leveraging their complementary capabilities to create an end-to-end offering on data discovery, linkage, privacy, curation and advanced analysis to enable their ecosystem and life sciences partners to create analytics-ready insights. This announcement follows the launch of Datavant Connect powered by AWS Clean Rooms, an enhanced capability that facilitates cloud-first data discovery and evaluation to accelerate time to insight. Through Datavant Connect, ecosystem partners' data is more easily and equitably accessible and able to be combined with complementary data sources, thus unlocking additional value to partners and customers alike. Aetion greatly enhances the Datavant Connect platform's data discovery features, and will enhance privacy assessments and give end-customers clean datasets and analytics they can leverage for a range of uses. In addition, the Aetion Evidence Platform is now available in AWS Marketplace. This announcement also coincides with the launch of Aetion® Activate. Activate expands Aetion's software portfolio to better serve biostatisticians and data scientists, creating a collaborative, auditable, and secure platform for both code and no-code users. It also removes the burdens of manual, error-prone data preparation—freeing teams to focus on research and critical analysis. Together with Datavant's connectivity and tokenization capabilities, Aetion now offers a more integrated ecosystem for preparing and analyzing real-world data at scale. 'Our mission at Aetion has always been to power critical decisions in healthcare with data science-driven technology,' said Jeremy Rassen, ScD, CEO of Aetion. 'By joining forces with Datavant, we'll unlock the full potential of real-world evidence to advance confident, data-driven decisions that improve patient care. Today, we are taking a bold step toward realizing our shared vision: a world where health data is seamlessly connected and actionable—so we can answer what treatments work, for whom, and what they should cost.' Upon closing, Datavant and Aetion will have a combined ecosystem of over 300 data partners. Datavant's RWD partners comprise datasets across electronic health records, claims, specialty pharmacy, registries, imaging, lab, social determinants of health, and more. With Aetion, RWD partners across the Datavant ecosystem will gain improved visibility of their data's utility through sharper querying of the datasets, scaling value, demand, and additional use cases across a more expansive base of life sciences companies. About Datavant Datavant is a health data platform company. We make the world's health data secure, accessible, and actionable. Datavant drives data connectivity into action by offering a proprietary platform and network that deliver critical solutions across the healthcare ecosystem. Datavant enables more than 60 million healthcare records to move between thousands of organizations, more than 70,000 hospitals and clinics, 75% of the 100 largest health systems, and an ecosystem of 300+ real-world data partners. To learn more about Datavant, visit and follow us on LinkedIn. About Aetion Aetion® is a global healthcare technology company that delivers real-world evidence (RWE) solutions to biopharmaceutical companies, medical device manufacturers, payers, and regulators. Powered by Aetion Evidence Platform®, Aetion applies advanced causal inference, rigorous epidemiologic methods, and purpose-built AI to transform complex healthcare data into transparent, reliable evidence on the safety, effectiveness, and value of medical treatments. Through this evidence-based approach, Aetion informs healthcare's most critical decisions—what works best, for whom, and when—while enabling scalable solutions for regulatory submissions, market access, and clinical development. Aetion's investors include Flare Capital Partners, NEA, Warburg Pincus, B Capital, and leading life sciences and payer organizations. Learn more at and follow us on LinkedIn.
Yahoo
15-05-2025
- Business
- Yahoo
Datavant to Acquire Aetion, Empowering Healthcare and Life Sciences Organizations to Generate High-Quality, Scalable Real-World Evidence from Connected, Privacy-Protected Data
Combination will enable faster, more actionable insights across the clinical and commercial lifecycle NEW YORK, May 15, 2025--(BUSINESS WIRE)--Datavant, a leading health data platform company, today announced that it has signed an agreement to acquire Aetion, a leading real-world evidence (RWE) platform that powers critical decision-making in healthcare. With this acquisition, Aetion will join Datavant to deliver an end-to-end RWE platform, enabling healthcare and life sciences companies to more efficiently answer research questions about the clinical impact of therapies in development and in market. This complementary combination unites two leaders to make RWE truly actionable, covering the full spectrum of services needed to deliver scientifically validated, transparent and reproducible RWE accepted by global regulators, including the FDA and EMA. Aetion brings industry-leading technology, services and data partners to help life science and medical device customers develop decision-grade evidence plans and analyses. Stakeholders across the healthcare value chain use Datavant's industry-standard platform for secure, compliant health data exchange to fuel connected, comprehensive insights that empower smarter decisions and advance patient outcomes. "As Datavant has grown and scaled, our life sciences and ecosystem partners have been asking us for a deeper capability set to bring together disparate data sources so they can tap into a more comprehensive and longitudinal view of patient health across the product lifecycle," said Kyle Armbrester, Chief Executive Officer, Datavant. "The addition of Aetion's team of scientists and technologists further bolsters our complementary capabilities and expertise so we can better leverage data from our ecosystem of partners to support efforts before, during, and after commercialization - generating evidence from trial to treatment and beyond to deliver life-improving therapies." The companies will focus on leveraging their complementary capabilities to create an end-to-end offering on data discovery, linkage, privacy, curation and advanced analysis to enable their ecosystem and life sciences partners to create analytics-ready insights. This announcement follows the launch of Datavant Connect powered by AWS Clean Rooms, an enhanced capability that facilitates cloud-first data discovery and evaluation to accelerate time to insight. Through Datavant Connect, ecosystem partners' data is more easily and equitably accessible and able to be combined with complementary data sources, thus unlocking additional value to partners and customers alike. Aetion greatly enhances the Datavant Connect platform's data discovery features, and will enhance privacy assessments and give end-customers clean datasets and analytics they can leverage for a range of uses. In addition, the Aetion Evidence Platform is now available in AWS Marketplace. This announcement also coincides with the launch of Aetion® Activate. Activate expands Aetion's software portfolio to better serve biostatisticians and data scientists, creating a collaborative, auditable, and secure platform for both code and no-code users. It also removes the burdens of manual, error-prone data preparation—freeing teams to focus on research and critical analysis. Together with Datavant's connectivity and tokenization capabilities, Aetion now offers a more integrated ecosystem for preparing and analyzing real-world data at scale. "Our mission at Aetion has always been to power critical decisions in healthcare with data science-driven technology," said Jeremy Rassen, ScD, CEO of Aetion. "By joining forces with Datavant, we'll unlock the full potential of real-world evidence to advance confident, data-driven decisions that improve patient care. Today, we are taking a bold step toward realizing our shared vision: a world where health data is seamlessly connected and actionable—so we can answer what treatments work, for whom, and what they should cost." Upon closing, Datavant and Aetion will have a combined ecosystem of over 300 data partners. Datavant's RWD partners comprise datasets across electronic health records, claims, specialty pharmacy, registries, imaging, lab, social determinants of health, and more. With Aetion, RWD partners across the Datavant ecosystem will gain improved visibility of their data's utility through sharper querying of the datasets, scaling value, demand, and additional use cases across a more expansive base of life sciences companies. About Datavant Datavant is a health data platform company. We make the world's health data secure, accessible, and actionable. Datavant drives data connectivity into action by offering a proprietary platform and network that deliver critical solutions across the healthcare ecosystem. Datavant enables more than 60 million healthcare records to move between thousands of organizations, more than 70,000 hospitals and clinics, 75% of the 100 largest health systems, and an ecosystem of 300+ real-world data partners. To learn more about Datavant, visit and follow us on LinkedIn. About Aetion Aetion® is a global healthcare technology company that delivers real-world evidence (RWE) solutions to biopharmaceutical companies, medical device manufacturers, payers, and regulators. Powered by Aetion Evidence Platform®, Aetion applies advanced causal inference, rigorous epidemiologic methods, and purpose-built AI to transform complex healthcare data into transparent, reliable evidence on the safety, effectiveness, and value of medical treatments. Through this evidence-based approach, Aetion informs healthcare's most critical decisions—what works best, for whom, and when—while enabling scalable solutions for regulatory submissions, market access, and clinical development. Aetion's investors include Flare Capital Partners, NEA, Warburg Pincus, B Capital, and leading life sciences and payer organizations. Learn more at and follow us on LinkedIn. View source version on Contacts Media Contact Lynn ShepherdHead of Corporate Communications, Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
